CELZ - CIK 0001187953
The table below shows CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$1.32M | -$1.59M | -$896.86K | -$3.84M | -$1.58M | -$441.52K |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$175.00K | $0.00 | $6.52M | $5.04M | $0.00 | $0.00 |
| Dividends paid | - | - | - | - | - |
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. reported operating cash flow of -$5.86M for fiscal year 2025. That is down 10.5% from -$5.30M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$445.23K (FY 2016) to -$5.86M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $0.00 | $10.00K | $82.80K | $0.00 | - | - |
| Financing cash flow | $13.36K | $3.35M | -$82.80K | $0.00 | $0.00 | $618.64K |